About UroGen Pharma Ltd.

UroGen Pharma Ltd. is a clinical stage pharmaceutical company, which engages in the provision of non-surgical and localized solutions for urological pathologies to address a clinical unmet need in field of uro-oncology. Its pipeline includes upper tract urothelial carcinoma, low grade non muscle invasive bladder cancer, carcinoma in situ of the bladder, and overactive bladder. The company was founded by Asher Holzer in 2004 and is headquartered in New York, NY.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -4.75$ per share.

The book value per share is 10.05$

UroGen Pharma Ltd. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- 100.00% -94M -244.50% -90M -4.75 - - 19M 10.05 -55M - -55M